Hairy Cell Leukemia: Where Are We in 2023? Andres Mendez-HernandezKrishna MoturiLeslie A. Andritsos ReviewPaper Open access 25 April 2023 Pages: 833 - 840
Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting Sean GreenLiora Schultz ReviewPaper 26 April 2023 Pages: 841 - 846
Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data Erin E. CrottyAshley L. WilsonNicholas A. Vitanza ReviewPaper Open access 09 May 2023 Pages: 847 - 855
Intratumoral Immunotherapy: Is It Ready for Prime Time? Mario GhosnLambros TselikasThierry De Baere ReviewPaper 02 May 2023 Pages: 857 - 867
Outcome Measures and Patient-Reported Metrics in Cancer Rehabilitation Mary M. Vargo ReviewPaper 06 May 2023 Pages: 869 - 882
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder Michelle LeeAseala AbousaudJean L. Koff ReviewPaper 10 May 2023 Pages: 883 - 895
Immunotherapy in Head and Neck Cancer: Where Do We Stand? Natalia G. VallianouAngelos EvangelopoulosMaria Dalamaga ReviewPaper 22 May 2023 Pages: 897 - 912
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer Jay ParekhKaushal ParikhAlfredo Addeo ReviewPaper Open access 30 May 2023 Pages: 913 - 922
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments Marwa SoltaniLara J. SokoloffMichael G. Fradley ReviewPaper 30 May 2023 Pages: 923 - 935
Diagnostic and Therapeutic Updates in Leptomeningeal Disease Meaghan A. Roy-O’ReillyTyler LanmanSeema Nagpal ReviewPaper Open access 31 May 2023 Pages: 937 - 950
Correction to: Current Status of Perioperative Therapy in Muscle‑Invasive Bladder Cancer and Future Directions Dillon C. CockrellTracy L. Rose Correction 20 April 2023 Pages: 951 - 953